You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Yttrium

Showing 1 - 25 of 444
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Yttrium-90 carbon microspheres SIRT
  • Nanjing, China
    Gao-Jun Teng
Jul 20, 2023

Unresectable Colorectal Liver Metastases Trial in Nanjing (Selective internal radiation therapy (SIRT) with yttrium-90 carbon

Recruiting
  • Unresectable Colorectal Liver Metastases
  • Selective internal radiation therapy (SIRT) with yttrium-90 carbon microspheres
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jan 26, 2023

Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)

Recruiting
  • Thrombocytopenia
  • Cirrhosis
  • TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Sep 7, 2022

Neodymium-doped Yttrium Aluminum Garnet Laser Capsulotomy

Active, not recruiting
  • Posterior Capsule Opacification Obscuring Vision
  • Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy
  • Tahlequah, Oklahoma
    Northeastern State University
Aug 30, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Cystic Tumors of the Sellar/Parasellar Region Trial in Halifax (90yttrium colloid)

Recruiting
  • Cystic Tumors of the Sellar/Parasellar Region
  • 90yttrium colloid
  • Halifax, Nova Scotia, Canada
    Halifax Infirmary
Jan 17, 2023

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT

Active, not recruiting
  • Advanced Adult Primary Liver Cancer
  • +3 more
  • positron emission tomography
  • computed tomography
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022

Inoperable Hepatocellular Carcinoma Trial in Nanjing (TheraSphere™ Yttrium-90 Glass Microspheres, conventional Transarterial

Recruiting
  • Inoperable Hepatocellular Carcinoma
  • TheraSphere™ Yttrium-90 Glass Microspheres
  • conventional Transarterial Chemoembolization(cTACE)
  • Nanjing, Jiangsu, China
    Zhongda Hospital Southeast University
Jul 22, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Completed
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Yttrium Y 90 Glass Microspheres
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Pigmentation, Gingiva Trial (Gingival depigmentation)

Completed
  • Pigmentation
  • Gingiva
  • Gingival depigmentation
  • (no location specified)
Oct 4, 2023

Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))

Completed
  • Liver Cancer
  • Hepatoma
  • Yttrium 90 (TheraSphere)
  • (no location specified)
Sep 28, 2022

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

Hepatic Malignancies Trial in Cleveland (PET/CT, PET/MR, SIRT with Y-90)

Completed
Has Results
  • Hepatic Malignancies
  • PET/CT
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jun 1, 2022

Leukemia Trial (90-Yttrium-labelled anti-CD66 mAb)

Not yet recruiting
  • Leukemia
  • 90-Yttrium-labelled anti-CD66 monoclonal antibody
  • (no location specified)
Aug 16, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial in Portland

Not yet recruiting
  • Hepatocellular Carcinoma
  • +8 more
  • Quality of Life
  • +3 more
  • Portland, Oregon
  • +1 more
Jun 20, 2022

Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Atezolizumab and Bevacizumab
  • Y90 + TKI
  • Chicago, Illinois
    Northwestern University
Nov 11, 2022

Stage IIIA Hepatocellular Carcinoma, Stage IIIB Hepatocellular Carcinoma, Stage IIIC Hepatocellular Carcinoma Trial in Chicago

Completed
Has Results
  • Stage IIIA Hepatocellular Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Jan 18, 2022